Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass

Article ID	Journal	Published Year	Pages	File Type
5597375	The Annals of Thoracic Surgery	2017	8 Pages	PDF

Abstract

Oral T3 supplementation may shorten time to extubation in children undergoing congenital heart disease operations, particularly infants aged 5 months or younger. Administration is relatively safe, simple and inexpensive.

Keywords

TTE modified intention to treat TRICC CAVC TAPVC PAPVC fT3 VSD COA TSH ESS TOF CPB IAA Coarctation of the aorta mITT Free T3 Los cardiopulmonary bypass intensive care unit ICU Tetralogy of Fallot Triiodothyronine Euthyroid sick syndrome length of stay confidence interval interrupted aortic arch hazard ratio Ventricular septal defect thyroid stimulating hormone complete atrioventricular canal

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Oral Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass

Authors

Eva M. MD, PhD, Cindy E. MD, PhD, Novik MD, Dicky MD, PhD, Poppy S. MD, Anwar MD, PhD, Sudigdo MD, PhD, April MS, Michael A. MD,